Search Results

Pexidartinib 100 mg  | 99.66%

TargetMol

Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.

More Information Supplier Page

Framycetin sulfate 50 mg  | 99.44%

TargetMol

Framycetin sulfate (Neomycin Sulphate B) belongs to aminoglycoside class of antibiotics that contain two or more aminosugars connected by glycosidic bonds.

More Information Supplier Page

Framycetin sulfate 25 mg  | 99.44%

TargetMol

Framycetin sulfate (Neomycin Sulphate B) belongs to aminoglycoside class of antibiotics that contain two or more aminosugars connected by glycosidic bonds.

More Information Supplier Page

Framycetin sulfate 100 mg  | 99.44%

TargetMol

Framycetin sulfate (Neomycin Sulphate B) belongs to aminoglycoside class of antibiotics that contain two or more aminosugars connected by glycosidic bonds.

More Information Supplier Page

Pexidartinib 5 mg  | 99.66%

TargetMol

Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.

More Information Supplier Page

Kaempferol 100 mg  | 99.11%

TargetMol

Kaempferol is a natural flavonoid which has been isolated from Delphinium, Witch-hazel, grapefruit, and other plant sources.

More Information Supplier Page

Kaempferol 200 mg  | 99.11%

TargetMol

Kaempferol is a natural flavonoid which has been isolated from Delphinium, Witch-hazel, grapefruit, and other plant sources.

More Information Supplier Page

AZD1208 5 mg  | 97.24%

TargetMol

AZD1208 is a novel, orally bioavailable, highly selective PIM kinase inhibitor with single nanomolar potency against all three PIM kinases.

More Information Supplier Page

AZD1208 10 mg  | 97.24%

TargetMol

AZD1208 is a novel, orally bioavailable, highly selective PIM kinase inhibitor with single nanomolar potency against all three PIM kinases.

More Information Supplier Page